EQL Pharma AB (publ) (STO:EQL)

Accolade Balance Sheet

Financials in millions SEK. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	82.4	20.47	44.43	41.2	26.58
Cash & Short-Term Investments	82.4	20.47	44.43	41.2	26.58
Cash Growth	302.58%	-53.93%	7.83%	55.01%	157.80%
Accounts Receivable	130.72	60.77	51.7	34.1	22.08
Other Receivables	1.4	5.21	0.96	0.71	4.22
Receivables	132.12	65.98	52.66	34.81	26.3
Inventory	179.03	105.63	65.37	41.67	42.36
Prepaid Expenses	6.25	4.75	4.2	2.24	0.32
Other Current Assets	0.45	0.94	0.57	3.53	2.27
Total Current Assets	400.25	197.77	167.23	123.45	97.82
Property, Plant & Equipment	6.33	2.67	3.15	4.19	5.01
Long-Term Investments	0	0	0	0	0
Other Intangible Assets	364.67	149.08	102.54	98.41	93.68
Long-Term Deferred Tax Assets	-	-	-	-	0.3
Long-Term Deferred Charges	37.58	24.24	12.78	11.83	6.7
Other Long-Term Assets	-0	-	-	-	-
Total Assets	808.82	373.76	285.7	237.89	203.51
Accounts Payable	90.94	49.83	29.61	15.98	19.03
Accrued Expenses	10.29	6.65	17.87	16.28	4.48
Short-Term Debt	107.41	102.22	63.7	59.32	64.41
Current Portion of Long-Term Debt	4.11	-	-	5.4	5.4
Current Portion of Leases	2.75	1.4	1.21	-	-
Current Income Taxes Payable	-	-	0.14	-	-
Other Current Liabilities	1.53	1.43	4.66	1.64	1.48
Total Current Liabilities	221.02	162.05	117.19	98.76	94.93
Long-Term Debt	338.39	15.45	-	7.2	12.6
Long-Term Leases	3.05	1.02	1.71	4.18	4.76
Long-Term Deferred Tax Liabilities	25.34	17.51	12.05	4.12	-
Other Long-Term Liabilities	0	-	0	-	-
Total Liabilities	587.79	196.03	130.94	114.26	112.29
Common Stock	1.31	1.31	1.31	1.31	1.31
Additional Paid-In Capital	67.64	67.45	67.18	66.99	66.13
Retained Earnings	152.08	108.97	86.26	55.33	23.78
Comprehensive Income & Other	-	-0	-	-	-
Shareholders' Equity	221.03	177.73	154.75	123.63	91.22
Total Liabilities & Equity	808.82	373.76	285.7	237.89	203.51
Total Debt	455.71	120.09	66.62	76.1	87.17
Net Cash (Debt)	-373.31	-99.63	-22.19	-34.9	-60.59
Net Cash Per Share	-12.49	-3.34	-0.75	-1.20	-2.08
Filing Date Shares Outstanding	29.06	29.06	29.06	29.06	29.06
Total Common Shares Outstanding	29.06	29.06	29.06	29.06	29.06
Working Capital	179.23	35.72	50.04	24.7	2.89
Book Value Per Share	7.61	6.12	5.32	4.25	3.14
Tangible Book Value	-143.63	28.65	52.21	25.21	-2.46
Tangible Book Value Per Share	-4.94	0.99	1.80	0.87	-0.08
Machinery	4.47	3.17	0.99	2.14	1.43

Updated Feb 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.